Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ZNF643 |
| Upstream (Parents) |
|---|
| (<<) THRA → ZNF643 |
| (<<) SOX4 → ZNF643 |
| (<<) GRHL2 → ZNF643 |
| (<<) TP53 → ZNF643 |
| (<<) MTA2 → ZNF643 |
| (<<) ZNF93 → ZNF643 |
| (<<) TRIM22 → ZNF643 |
| (<<) MAFB → ZNF643 |
| (<<) ZFHX4 → ZNF643 |
| (<<) CBFA2T2 → ZNF643 |
| (<<) HCLS1 → ZNF643 |
| (<<) PBX2 → ZNF643 |
| (<<) ZNF202 → ZNF643 |
| (<<) NR2F2 → ZNF643 |
| Downstream (Children) |
|---|
| ZNF643 → ELF5 (>>) |
| ZNF643 → PGR (>>) |
| ZNF643 → RFXAP (>>) |
| ZNF643 → MECOM (>>) |
| ZNF643 → ZNF3 (>>) |
| ZNF643 → BLZF1 (>>) |
| ZNF643 → PHF1 (>>) |
| ZNF643 → HOXA3 (>>) |
| ZNF643 → E2F4 (>>) |
